ES2140870T3 - Deteccion de potenciales transmembrana por metodos opticos. - Google Patents
Deteccion de potenciales transmembrana por metodos opticos.Info
- Publication number
- ES2140870T3 ES2140870T3 ES96921410T ES96921410T ES2140870T3 ES 2140870 T3 ES2140870 T3 ES 2140870T3 ES 96921410 T ES96921410 T ES 96921410T ES 96921410 T ES96921410 T ES 96921410T ES 2140870 T3 ES2140870 T3 ES 2140870T3
- Authority
- ES
- Spain
- Prior art keywords
- membrane
- energy
- transfer
- reagent
- potential
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title abstract 4
- 238000001514 detection method Methods 0.000 title 1
- 230000003287 optical effect Effects 0.000 title 1
- 239000012528 membrane Substances 0.000 abstract 8
- 239000003153 chemical reaction reagent Substances 0.000 abstract 5
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000005281 excited state Effects 0.000 abstract 1
- 230000002209 hydrophobic effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000005855 radiation Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
- C07D239/62—Barbituric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
- C07D239/66—Thiobarbituric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/003—Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/027—Organoboranes and organoborohydrides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/10—Phosphatides, e.g. lecithin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
- C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
- C09B23/02—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5058—Neurological cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5061—Muscle cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5076—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving cell organelles, e.g. Golgi complex, endoplasmic reticulum
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/805—Optical property
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
- Measuring Instrument Details And Bridges, And Automatic Balancing Devices (AREA)
- Traffic Control Systems (AREA)
- Image Input (AREA)
- Photometry And Measurement Of Optical Pulse Characteristics (AREA)
- Measurement Of Current Or Voltage (AREA)
- Electrostatic Charge, Transfer And Separation In Electrography (AREA)
- Elimination Of Static Electricity (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
SE PRESENTAN LOS METODOS Y LAS COMPOSICIONES PARA DETERMINAR EL POTENCIAL DE UNA MEMBRANA. EN UN ASPECTO, EL METODO CONSISTE EN: A) LA INTRODUCCION DE UN PRIMER REACTIVO FORMADO POR UN ION HIDROFOBO FLUORESCENTE CAPAZ DE REDISTRIBUIRSE DESDE UN PRIMER LADO DE LA MEMBRANA A UN SEGUNDO LADO DE LA MEMBRANA COMO RESPUESTA A CAMBIOS EN EL POTENCIAL DE LA MEMBRANA, SEGUN SE DESCRIBE CON LA ECUACION DE NERST; B) LA INTRODUCCION DE UN SEGUNDO REACTIVO QUE MARCA EL PRIMER O EL SEGUNDO LADO DE LA MEMBRANA, ESTANDO FORMADO ESTE SEGUNDO REACTIVO POR UN CROMOFORO CAPAZ DE TRANSFERIR ENERGIA MEDIANTE I) LA DONACION DE LA ENERGIA EN ESTADO EXCITADO AL ION FLUORESCENTE, O II) LA ACEPTACION DE LA ENERGIA DEL ESTADO EXCITADO PROCEDENTE DEL ION FLUORESCENTE; C) LA EXPOSICION DE LA MEMBRANA A LA RADIACION; D) LA DETERMINACION DE LA TRANSFERENCIA DE ENERGIA ENTRE EL ION FLUORESCENTE Y EL SEGUNDO REACTIVO; Y E) RELACIONAR LA TRANSFERENCIA DE ENERGIA CON EL POTENCIAL DE MEMBRANA. LA TRANSFERENCIA DE ENERGIA SE MIDE TIPICAMENTE MEDIANTE LA TRANSFERENCIA DE LA ENERGIA DE RESONANCIA DE FLUORESCENCIA. EN ALGUNAS REALIZACIONES EL PRIMER Y SEGUNDO REACTIVOS ESTAN UNIDOS MEDIANTE UN VINCULO ADECUADO. EN UNA REALIZACION, EL METODO SE UTILIZA PARA IDENTIFICAR COMPUESTOS QUE MODULEN LOS POTENCIALES DE MEMBRANA EN MEMBRANAS BIOLOGICAS.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US481977 | 1995-06-07 | ||
US08/481,977 US5661035A (en) | 1995-06-07 | 1995-06-07 | Voltage sensing by fluorescence resonance energy transfer |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2140870T3 true ES2140870T3 (es) | 2000-03-01 |
ES2140870T5 ES2140870T5 (es) | 2006-04-16 |
Family
ID=23914150
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES96921410T Expired - Lifetime ES2140870T5 (es) | 1995-06-07 | 1996-06-06 | Deteccion de potenciales transmembrana por metodos opticos. |
Country Status (11)
Country | Link |
---|---|
US (2) | US5661035A (es) |
EP (3) | EP0977035B2 (es) |
JP (2) | JP4033899B2 (es) |
AT (2) | ATE304706T1 (es) |
AU (1) | AU716130B2 (es) |
CA (1) | CA2223927C (es) |
DE (2) | DE69635193T3 (es) |
DK (1) | DK0834074T4 (es) |
ES (1) | ES2140870T5 (es) |
HK (1) | HK1090422A1 (es) |
WO (1) | WO1996041166A2 (es) |
Families Citing this family (103)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6028190A (en) | 1994-02-01 | 2000-02-22 | The Regents Of The University Of California | Probes labeled with energy transfer coupled dyes |
US5661035A (en) * | 1995-06-07 | 1997-08-26 | The Regents Of The University Of California | Voltage sensing by fluorescence resonance energy transfer |
US6008373A (en) | 1995-06-07 | 1999-12-28 | Carnegie Mellon University | Fluorescent labeling complexes with large stokes shift formed by coupling together cyanine and other fluorochromes capable of resonance energy transfer |
US6342379B1 (en) * | 1995-06-07 | 2002-01-29 | The Regents Of The University Of California | Detection of transmembrane potentials by optical methods |
US6596522B2 (en) * | 1997-05-08 | 2003-07-22 | The Regents Of The University Of California | Detection of transmembrane potentials by optical methods |
US7388092B2 (en) | 1996-05-03 | 2008-06-17 | Applera Corporation | Oligonucleotides and analogs labeled with energy transfer dyes |
US5945526A (en) | 1996-05-03 | 1999-08-31 | Perkin-Elmer Corporation | Energy transfer dyes with enhanced fluorescence |
US6593135B2 (en) * | 1996-08-16 | 2003-07-15 | The State Of Oregon, Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon | Long wavelength engineered fluorescent proteins |
AT405103B (de) * | 1996-10-16 | 1999-05-25 | Avl Verbrennungskraft Messtech | Sensorschicht zur quantitativen bestimmung zumindest einer chemischen komponente einer gasförmigen oder flüssigen probe |
FR2756633B1 (fr) * | 1996-11-29 | 1999-01-15 | Centre Nat Rech Scient | Methode de detection in vitro du potentiel transmembranaire mitochondrial |
US6342345B1 (en) | 1997-04-02 | 2002-01-29 | The Board Of Trustees Of The Leland Stanford Junior University | Detection of molecular interactions by reporter subunit complementation |
FR2764387B1 (fr) | 1997-06-05 | 1999-07-23 | Centre Nat Rech Scient | Utilisation d'une proteine fluorescente pour la detection d'interactions entre une proteine cible et son ligand |
US6214563B1 (en) | 1997-08-01 | 2001-04-10 | Aurora Biosciences Corporation | Photon reducing agents for reducing undesired light emission in assays |
US6200762B1 (en) | 1997-08-01 | 2001-03-13 | Aurora Biosciences Corporation | Photon reducing agents and compositions for fluorescence assays |
US6221612B1 (en) * | 1997-08-01 | 2001-04-24 | Aurora Biosciences Corporation | Photon reducing agents for use in fluorescence assays |
US6348322B1 (en) * | 1997-10-17 | 2002-02-19 | Duke University | Method of screening for specific binding interactions |
US7244349B2 (en) * | 1997-12-17 | 2007-07-17 | Molecular Devices Corporation | Multiaperture sample positioning and analysis system |
EP1053253A4 (en) * | 1998-02-05 | 2004-09-29 | Merck & Co Inc | NEW DNA SEQUENCES CODING A GABA B RECEPTOR. |
US20030036855A1 (en) * | 1998-03-16 | 2003-02-20 | Praelux Incorporated, A Corporation Of New Jersey | Method and apparatus for screening chemical compounds |
US6388788B1 (en) | 1998-03-16 | 2002-05-14 | Praelux, Inc. | Method and apparatus for screening chemical compounds |
US6592847B1 (en) * | 1998-05-14 | 2003-07-15 | The General Hospital Corporation | Intramolecularly-quenched near infrared flourescent probes |
US6083486A (en) * | 1998-05-14 | 2000-07-04 | The General Hospital Corporation | Intramolecularly-quenched near infrared fluorescent probes |
AU4188599A (en) * | 1998-05-15 | 1999-12-06 | Geron Corporation | Method and apparatus for detecting hazardous agents |
US5998146A (en) * | 1998-07-17 | 1999-12-07 | Wallac Oy | Homogeneous luminescence assay method based on energy transfer |
JP2002532487A (ja) * | 1998-12-14 | 2002-10-02 | オーロラ バイオサイエンシーズ コーポレイション | シトクロムp450活性に対する光学分子センサ |
US6420130B1 (en) * | 1998-12-14 | 2002-07-16 | Aurora Biosciences Corporation | Optical molecular sensors for cytochrome P450 activity |
US8148110B2 (en) | 1999-03-15 | 2012-04-03 | The Board Of Trustees Of The Leland Stanford Junior University | Detection of molecular interactions by β-lactamase reporter fragment complementation |
US6285909B1 (en) | 1999-05-27 | 2001-09-04 | Cardiac Pacemakers, Inc. | Preserving patient specific data in implantable pulse generator systems |
US6662039B2 (en) * | 1999-06-18 | 2003-12-09 | The Trustees Of Columbia University In The City Of New York | Optical probing of neuronal connections with fluorescent indicators |
US6323039B1 (en) | 1999-06-22 | 2001-11-27 | Mitokor | Compositions and methods for assaying subcellular conditions and processes using energy transfer |
AU5763600A (en) * | 1999-06-22 | 2001-01-09 | Mitokor | Compositions and methods for assaying subcellular conditions and processes usingenergy transfer |
WO2001005828A1 (en) * | 1999-07-20 | 2001-01-25 | Merck & Co., Inc. | Novel human calcium sensitive potassium channel subunits |
US6358684B1 (en) | 1999-08-27 | 2002-03-19 | Pe Corporation | UV excitable fluorescent energy transfer dyes |
ATE261583T1 (de) * | 1999-09-01 | 2004-03-15 | Invitrogen Corp | Photon dämpfer für fluoreszenzassays |
US6468763B1 (en) | 1999-09-29 | 2002-10-22 | Caliper Technologies Corp. | Optical detection of transmembrane potential changes |
US6537771B1 (en) * | 1999-10-08 | 2003-03-25 | Caliper Technologies Corp. | Use of nernstein voltage sensitive dyes in measuring transmembrane voltage |
US6740466B1 (en) * | 1999-11-15 | 2004-05-25 | Fuji Photo Film Co., Ltd. | Photopolymerizable composition and recording material using the same |
GB0003069D0 (en) * | 2000-02-11 | 2000-03-29 | Cambridge Drug Discovery Ltd | Improved assay |
US6287758B1 (en) * | 2000-03-23 | 2001-09-11 | Axiom Biotechnologies, Inc. | Methods of registering trans-membrane electric potentials |
JP2004500119A (ja) | 2000-03-31 | 2004-01-08 | メルク エンド カムパニー インコーポレーテッド | デルマセンター・ヴァリァビリスgaba依存性塩素イオンチャンネル |
US6686193B2 (en) | 2000-07-10 | 2004-02-03 | Vertex Pharmaceuticals, Inc. | High throughput method and system for screening candidate compounds for activity against target ion channels |
DE60123797T2 (de) * | 2000-07-10 | 2007-10-18 | Vertex Pharmaceuticals (San Diego) Llc, San Diego | Ionenkanal-testverfahren |
JP5603850B2 (ja) * | 2000-07-10 | 2014-10-08 | ヴァーテックス ファーマシューティカルズ (サンディエゴ)エルエルシー | イオンチャネルアッセイ法 |
US7615356B2 (en) | 2000-07-10 | 2009-11-10 | Vertex Pharmaceuticals (San Diego) Llc | Ion channel assay methods |
WO2002042842A2 (en) * | 2000-11-22 | 2002-05-30 | Allergan, Inc. | A high-throughput screen for identifying channel blockers that selectively distinguish transient from persistent sodium channels |
US7383076B2 (en) * | 2000-11-27 | 2008-06-03 | The General Hospital Corporation | Fluorescence-mediated molecular tomography |
US20030044353A1 (en) * | 2001-01-05 | 2003-03-06 | Ralph Weissleder | Activatable imaging probes |
US20030211575A1 (en) * | 2001-02-07 | 2003-11-13 | Swartz Kenton J. | Constituitively open voltage-gated kand methods for discovering modulators thereof |
US7005511B2 (en) | 2001-02-26 | 2006-02-28 | The Regents Of The University Of California | Fluorescent protein variants and methods for making same |
US20040146849A1 (en) * | 2002-01-24 | 2004-07-29 | Mingxian Huang | Biochips including ion transport detecting structures and methods of use |
US20050009004A1 (en) * | 2002-05-04 | 2005-01-13 | Jia Xu | Apparatus including ion transport detecting structures and methods of use |
AU2002307218A1 (en) * | 2001-03-24 | 2002-10-08 | Aviva Biosciences Corporation | Biochips including ion transport detecting structures and methods of use |
US20050058990A1 (en) * | 2001-03-24 | 2005-03-17 | Antonio Guia | Biochip devices for ion transport measurement, methods of manufacture, and methods of use |
US20050196746A1 (en) * | 2001-03-24 | 2005-09-08 | Jia Xu | High-density ion transport measurement biochip devices and methods |
US20060029955A1 (en) * | 2001-03-24 | 2006-02-09 | Antonio Guia | High-density ion transport measurement biochip devices and methods |
WO2002101364A1 (en) * | 2001-06-09 | 2002-12-19 | Glsynthesis Inc. | Lipid structures and uses thereof |
DE10130172A1 (de) * | 2001-06-22 | 2003-01-09 | Evotec Ag | Fluoreszenz-Farbstoffderivate |
FR2826666B1 (fr) * | 2001-07-02 | 2004-07-02 | Novaleads | Procede de selection d'agents bio-actifs par couplage de luminescence et systeme cellulaire vivant pour la mise en oeuvre de ce procede |
JP2005514909A (ja) * | 2001-07-12 | 2005-05-26 | メルク エンド カムパニー インコーポレーテッド | 真核生物細胞の電場による刺激 |
US7361478B2 (en) | 2001-11-20 | 2008-04-22 | Allergan, Inc. | High-throughput screen for identifying selective persistent sodium channels channel blockers |
US20070197583A1 (en) * | 2002-03-29 | 2007-08-23 | Welsh Michael J | Novel compositions and methods for modulation of the acid-sensing ion channel (ASIC) for the treatment of anxiety and drug addiction |
US20030186860A1 (en) * | 2002-03-29 | 2003-10-02 | Welsh Michael J. | Novel compositions and methods for modulating the acid-sensing ion channel (ASIC) |
US20050181464A1 (en) * | 2002-04-04 | 2005-08-18 | Affinium Pharmaceuticals, Inc. | Novel purified polypeptides from bacteria |
EP1501924A4 (en) * | 2002-05-04 | 2006-05-24 | Aviva Biosciences Corp | DEVICE WITH STRUCTURES OF PROTECTIVE ION TRANSPORT AND USE METHOD |
US20030228566A1 (en) * | 2002-06-11 | 2003-12-11 | Biotechplex Corporation | Method of and apparatus for screening for drug candidates |
US7427489B1 (en) * | 2002-06-17 | 2008-09-23 | The Scripps Research Institute | Screening assay to identify modulators of the sleep/wake cycle |
WO2004033647A2 (en) | 2002-10-10 | 2004-04-22 | Merck & Co., Inc. | Assay methods for state-dependent calcium channel agonists/antagonists |
US20050037364A1 (en) | 2003-08-13 | 2005-02-17 | International Business Machines Corporation | Techniques for recording signals |
US7060723B2 (en) * | 2003-08-29 | 2006-06-13 | Allergan, Inc. | Treating neurological disorders using selective antagonists of persistent sodium current |
US7125908B2 (en) * | 2003-08-29 | 2006-10-24 | Allergan, Inc. | Treating pain using selective antagonists of persistent sodium current |
US8329390B2 (en) * | 2004-10-21 | 2012-12-11 | Anaspec Incorporated | Detection of transmembrane potentials using N,N,N′-trialkyl thiobarbituric acid-derived polymethine oxonols |
US8709804B2 (en) | 2004-12-21 | 2014-04-29 | Cedars-Sinai Medical Center | Method for drug screening and characterization by calcium flux |
FR2890174B1 (fr) * | 2005-08-30 | 2009-04-24 | Cis Bio Internat Sa | Procede pour la mise en evidence d'un processus biologique par mesure d'un fret |
US7998749B2 (en) * | 2005-10-12 | 2011-08-16 | Allergan, Inc. | Assays of molecular or subcellular interactivity using depolarization after resonance transfer energy (DARET) |
US20070254276A1 (en) * | 2006-04-26 | 2007-11-01 | Seng Enterprises Ltd. | Method and system for measuring membrane potential based on fluorescence polarization |
US9006283B2 (en) * | 2007-07-12 | 2015-04-14 | Acumen Pharmaceuticals, Inc. | Methods of modifying amyloid β oligomers using non-peptidic compounds |
US20110098309A1 (en) * | 2007-07-12 | 2011-04-28 | Acumen Pharmaceuticals, Inc. | Methods of inhibiting the formation of amyloid-beta diffusable ligands using acylhydrazide compounds |
US8962677B2 (en) | 2007-07-12 | 2015-02-24 | Acumen Pharmaceuticals, Inc. | Methods of restoring cognitive ability using non-peptidic compounds |
EP2244741B1 (en) | 2008-01-18 | 2015-03-25 | VisEn Medical, Inc. | Fluorescent imaging agents |
US20090291150A1 (en) * | 2008-05-21 | 2009-11-26 | University Of Iowa Research Foundation | Method and compositions for treating and preventing seizures by modulating acid-sensing ion channel activity |
CA2747244A1 (en) | 2008-12-12 | 2010-06-17 | University Of Florida Research Foundation, Inc. | Cell-based detection of apf through its interaction with ckap4 for diagnosis of interstitial cystitis |
WO2010117420A2 (en) * | 2009-03-30 | 2010-10-14 | Pacific Biosciences Of California, Inc. | Fret-labeled compounds and uses therefor |
US9222043B2 (en) * | 2009-09-22 | 2015-12-29 | Authentix, Inc. | Dipyrromethenes and azadipyrromethenes as markers for petroleum products |
US9207237B2 (en) | 2010-08-23 | 2015-12-08 | President And Fellows Of Harvard College | Systems, methods, and workflows for optogenetics analysis |
US9057734B2 (en) | 2010-08-23 | 2015-06-16 | President And Fellows Of Harvard College | Optogenetic probes for measuring membrane potential |
WO2013130808A1 (en) | 2012-02-29 | 2013-09-06 | D.E. Shaw Research, Llc | Methods for screening voltage gated proteins |
WO2014005125A2 (en) * | 2012-06-29 | 2014-01-03 | Biotium, Inc. | Fluorescent compounds and uses thereof |
KR101933620B1 (ko) * | 2012-09-18 | 2018-12-28 | 삼성전자주식회사 | 소포를 검출하기 위한 조성물, 키트 및 이를 이용하여 소포를 분석하는 방법 |
US10175174B2 (en) | 2012-12-11 | 2019-01-08 | Ge Healthcare Bio-Sciences Corp. | Photoactivated chemical bleaching of dyes |
JP6321634B2 (ja) | 2013-05-23 | 2018-05-09 | 学校法人慶應義塾 | 光第二高調波発生化合物、光第二高調波発生色素組成物及び細胞検査方法 |
US9063420B2 (en) | 2013-07-16 | 2015-06-23 | Rohm And Haas Electronic Materials Llc | Photoresist composition, coated substrate, and method of forming electronic device |
US8933239B1 (en) | 2013-07-16 | 2015-01-13 | Dow Global Technologies Llc | Bis(aryl)acetal compounds |
US8962779B2 (en) | 2013-07-16 | 2015-02-24 | Dow Global Technologies Llc | Method of forming polyaryl polymers |
US9410016B2 (en) | 2013-07-16 | 2016-08-09 | Dow Global Technologies Llc | Aromatic polyacetals and articles comprising them |
WO2015195769A2 (en) | 2014-06-18 | 2015-12-23 | President And Fellows Of Harvard College | Optogenetic probes for measuring membrane potential |
CN104357045B (zh) * | 2014-11-05 | 2016-06-01 | 北京化工大学 | 具有极酸/极碱开关响应的螺吡喃小分子荧光探针的合成方法及其应用 |
US10077463B2 (en) | 2015-01-15 | 2018-09-18 | President And Fellows Of Harvard College | Optical selection of cells |
EP3314255B1 (en) * | 2015-06-25 | 2019-07-31 | H. Hoffnabb-La Roche Ag | Cell based assay for determining antibody or ligand binding and function |
EP3589639A4 (en) | 2017-03-02 | 2021-03-17 | Akita Innovations LLC | TENSION SENSITIVE DYES |
WO2019212946A1 (en) | 2018-04-30 | 2019-11-07 | Ribon Therapeutics Inc. | Screening methods for parp modulators |
EP3823674A4 (en) | 2018-07-18 | 2022-12-28 | Manzanita Pharmaceuticals, Inc. | CONJUGATES FOR DELIVERING AN ANTI-CANCER AGENT TO NERVE CELLS, METHODS OF USE AND METHODS OF PRODUCTION THEREOF |
RU197959U1 (ru) * | 2020-01-28 | 2020-06-09 | Федеральное государственное бюджетное образовательное учреждение высшего образования "МИРЭА - Российский технологический университет" | Устройство для исследования компонент вещества с помощью микроволновой плазмы методами оптической и ямр спектроскопии |
WO2022008720A1 (en) * | 2020-07-10 | 2022-01-13 | Life & Brain Gmbh | Novel hybrid optical voltage sensors |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1597482B2 (de) * | 1967-09-22 | 1977-03-24 | Agfa-Gevaert Ag, 5090 Leverkusen | Lichtempfindliches photographisches aufzeichnungsmaterial mit lichthofschutz- oder filterfarbstoffen |
JPS59218956A (ja) * | 1983-05-27 | 1984-12-10 | Fujirebio Inc | 膜融合測定方法 |
DK487784A (da) * | 1983-10-13 | 1985-04-14 | Univ Georgia | Immunoassay |
US4647531A (en) * | 1984-02-06 | 1987-03-03 | Ortho Diagnostic Systems, Inc. | Generalized cytometry instrument and methods of use |
US4861727A (en) * | 1986-09-08 | 1989-08-29 | C. R. Bard, Inc. | Luminescent oxygen sensor based on a lanthanide complex |
US4900934A (en) * | 1987-07-15 | 1990-02-13 | University Of Utah | Apparatus for simultaneous visualization and measurement of fluorescence from fluorescent dye-treated cell preparations and solutions |
AT393035B (de) * | 1989-04-25 | 1991-07-25 | Avl Verbrennungskraft Messtech | Verfahren zur quantitativen bestimmung zumindest eines chemischen parameters eines probenmediums |
US5169788A (en) * | 1989-06-09 | 1992-12-08 | New England Deaconess Hospital Corporation | Methods of measuring membrane potential using j-aggregate forming dyes |
DK0429907T3 (da) * | 1989-11-21 | 1994-10-03 | Bayer Ag | Optisk biosensor |
US5244813A (en) * | 1991-01-25 | 1993-09-14 | Trustees Of Tufts College | Fiber optic sensor, apparatus, and methods for detecting an organic analyte in a fluid or vapor sample |
DE4121426A1 (de) * | 1991-06-28 | 1993-01-14 | Basf Ag | Chemischer sensor |
EP0552107A1 (en) * | 1992-01-17 | 1993-07-21 | The University Of Maryland At Baltimore | pH and pCO2, sensing by luminescent lifetimes and energy transfer |
WO1995008637A1 (en) * | 1993-09-21 | 1995-03-30 | Washington State University Research Foundation | Immunoassay comprising ligand-conjugated, ion channel receptor immobilized in lipid film |
GB9406464D0 (en) * | 1994-03-31 | 1994-05-25 | British Tech Group | Assay for determining biochemical changes at phospholipid bilayer membrane surfaces |
US5661035A (en) * | 1995-06-07 | 1997-08-26 | The Regents Of The University Of California | Voltage sensing by fluorescence resonance energy transfer |
-
1995
- 1995-06-07 US US08/481,977 patent/US5661035A/en not_active Expired - Lifetime
-
1996
- 1996-06-06 ES ES96921410T patent/ES2140870T5/es not_active Expired - Lifetime
- 1996-06-06 CA CA002223927A patent/CA2223927C/en not_active Expired - Lifetime
- 1996-06-06 DK DK96921410T patent/DK0834074T4/da active
- 1996-06-06 US US08/765,860 patent/US6107066A/en not_active Expired - Lifetime
- 1996-06-06 AT AT99113781T patent/ATE304706T1/de not_active IP Right Cessation
- 1996-06-06 AU AU62643/96A patent/AU716130B2/en not_active Expired
- 1996-06-06 WO PCT/US1996/009652 patent/WO1996041166A2/en active IP Right Grant
- 1996-06-06 EP EP99113781A patent/EP0977035B2/en not_active Expired - Lifetime
- 1996-06-06 DE DE69635193T patent/DE69635193T3/de not_active Expired - Lifetime
- 1996-06-06 EP EP05015762.7A patent/EP1610126B1/en not_active Expired - Lifetime
- 1996-06-06 EP EP96921410A patent/EP0834074B2/en not_active Expired - Lifetime
- 1996-06-06 DE DE69605041T patent/DE69605041T3/de not_active Expired - Lifetime
- 1996-06-06 JP JP50192697A patent/JP4033899B2/ja not_active Expired - Lifetime
- 1996-06-06 AT AT96921410T patent/ATE186400T1/de active
-
2004
- 2004-04-27 JP JP2004131475A patent/JP4064945B2/ja not_active Expired - Lifetime
-
2006
- 2006-06-23 HK HK06107168.5A patent/HK1090422A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU716130B2 (en) | 2000-02-17 |
DE69605041T3 (de) | 2006-09-21 |
DE69605041D1 (de) | 1999-12-09 |
JPH11508355A (ja) | 1999-07-21 |
HK1090422A1 (en) | 2006-12-22 |
AU6264396A (en) | 1996-12-30 |
US5661035A (en) | 1997-08-26 |
EP1610126B1 (en) | 2014-04-30 |
EP0834074A1 (en) | 1998-04-08 |
EP0977035B2 (en) | 2010-07-21 |
CA2223927A1 (en) | 1996-12-19 |
EP0977035A2 (en) | 2000-02-02 |
EP0834074B1 (en) | 1999-11-03 |
EP1610126A1 (en) | 2005-12-28 |
DE69635193D1 (de) | 2005-10-20 |
DE69605041T2 (de) | 2000-03-16 |
EP0977035B1 (en) | 2005-09-14 |
WO1996041166A2 (en) | 1996-12-19 |
DE69635193T3 (de) | 2011-03-10 |
DK0834074T4 (da) | 2005-12-12 |
DK0834074T3 (da) | 2000-04-03 |
WO1996041166A3 (en) | 1997-05-15 |
DE69635193T2 (de) | 2006-01-19 |
EP0834074B2 (en) | 2005-11-16 |
ES2140870T5 (es) | 2006-04-16 |
CA2223927C (en) | 2004-04-06 |
JP4033899B2 (ja) | 2008-01-16 |
US6107066A (en) | 2000-08-22 |
JP2004231666A (ja) | 2004-08-19 |
JP4064945B2 (ja) | 2008-03-19 |
ATE186400T1 (de) | 1999-11-15 |
EP0977035A3 (en) | 2000-03-01 |
ATE304706T1 (de) | 2005-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2140870T3 (es) | Deteccion de potenciales transmembrana por metodos opticos. | |
Zhu et al. | Zero-mode waveguides for single-molecule analysis | |
ATE544747T1 (de) | Erkennung von transmembranpotentialen durch optische verfahren | |
Dybko et al. | Assessment of water quality based on multiparameter fiber optic probe | |
ES2052610T3 (es) | Un metodo de determinacion de anfetamina y/o metanfetamina en una muestra de ensayo. | |
WO2005094285A3 (en) | Percutaneous chemical sensor based on fluorescence resonant energy transfer (fret) | |
WO2003027741A3 (en) | Biochemical assay detection in a liquid receptacle using a fiber optic exciter | |
DK1029233T3 (da) | Måling af koncentrationen af et stof | |
BR9813478A (pt) | Sensor para gases múltiplos | |
WO2001071350A3 (en) | Methods of registering trans-membrane electric potentials | |
US11559248B2 (en) | Real-time parathyroid sensing system | |
DE59808993D1 (de) | Verfahren und vorrichtung zur fluoreszenzkorrelationsspektroskopie, insbesondere zur mehrfarben-fluoreszenzkorrelationsspektroskopie | |
ATE383572T1 (de) | Probenträger mit integrierter optik | |
Gaur et al. | Emergence through delicate balance between the steric factor and molecular orientation: a highly bright and photostable DNA marker for real-time monitoring of cell growth dynamics | |
Castelletto et al. | Viral particle imaging by super-resolution fluorescence microscopy | |
Raut et al. | Localization-based super-resolution microscopy reveals relationship between SARS-CoV2 spike and phosphatidylinositol (4, 5): biphosphate | |
CN111088144B (zh) | 单分子dna荧光信号检测系统及阵列微孔的检测方法 | |
ATE142335T1 (de) | Vorrichtung zur durchführung mehrerer gleichzeitiger messungen electrochemilumineszenter phänomene | |
DK0653633T3 (da) | Toksicitetstestassay | |
US20110200989A1 (en) | Single molecule nucleic acid sequencing using multiphoton fluorescence excitation | |
RU2689286C2 (ru) | Датчик кислорода, содержащий оптическое волокно большого диаметра с покрытым наконечником | |
Vekshin et al. | Artefacts of confocal microscopy | |
JPH11148919A (ja) | キャピラリチップ | |
US8581211B2 (en) | Imaging method and system using substrate functionalization | |
ES2122464T3 (es) | Procedimiento y dispositivo de control de estructuras alveolares con ayuda de fibras opticas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 834074 Country of ref document: ES |